Follow The Filings

BHC Bausch Health Companies Inc.

Health Care, filed as BAUSCH HEALTH COS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 14.0%
  • $361M

Who owns this now

Largest portfolio weights among holders, up to 14.0% (John Paulson, Paulson & Co.). Not free-float ownership.

  1. John Paulson 14.0%

Who owns BHC

Sorted by value, long equity only, as of 2026 Q2.

History
John Paulson, Paulson & Co. 14.0% Hold 73,255,869 $361M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BHC insider trades
  • $15.6M bought by 1 insider
  • None no sales outside a trading plan
  • $507K sold by 3 insiders under 10b5-1 plans
  1. Aimee J. Lenar President, US Pharma
    Planned sale
    $259K 36,827 shares at $7.03 9.9% of stake
    Traded Aug 19 Filed Aug 20
    ↗
  2. Frank D. Lee Director
    Planned sale
    $133K 24,456 shares at $5.43 33% of stake
    Traded May 19 Filed May 20
    ↗
  3. Seana Carson EVP, General Counsel
    Planned sale
    $65K 11,276 shares at $5.78 1.8% of stake
    Traded Mar 2–3 Filed Mar 3
    ↗
  4. Seana Carson EVP, General Counsel
    Planned sale
    $50K 8,388 shares at $5.95 1% of stake
    Traded Feb 27 Filed Feb 27
    ↗
  5. Paulson & Co. Inc. 10% owner
    Buy
    $15.6M 2,500,000 shares at $6.25 +3.5% to stake
    Traded Nov 25, 2025 Filed Nov 28, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 28 stock grants, 12 share withholdings for taxes, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $8.76B $9.62B $10.27B
Net income -$592M -$46M $157M
Net margin * -6.8% -0.5% 1.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $5.6B $5.77B $6.16B
Total non-current assets * $21.75B $20.75B $20.21B
Total assets $27.35B $26.52B $26.37B
Total current liabilities $4.3B $6.75B $4.18B
Total non-current liabilities * $23.13B $20.09B $21.81B
Total equity -$1.02B -$1.28B -$0.554B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.03B $1.6B $1.4B
Cash from investing -$2.14B -$0.454B -$0.595B
Cash from financing $1.48B -$0.868B -$0.742B
Net change in cash $371M $239M $124M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.